These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9871615

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups.
    Mendoza MF, Hollabaugh NM, Hettiarachchi SU, McCarley RL.
    Biochemistry; 2012 Oct 09; 51(40):8014-26. PubMed ID: 22989153
    [Abstract] [Full Text] [Related]

  • 23. Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents.
    Cai W, Hassani M, Karki R, Walter ED, Koelsch KH, Seradj H, Lineswala JP, Mirzaei H, York JS, Olang F, Sedighi M, Lucas JS, Eads TJ, Rose AS, Charkhzarrin S, Hermann NG, Beall HD, Behforouz M.
    Bioorg Med Chem; 2010 Mar 01; 18(5):1899-909. PubMed ID: 20149966
    [Abstract] [Full Text] [Related]

  • 24. 3-substituted-5-aziridinyl-1-methylindole-4,7-diones as NQO1-directed antitumour agents: mechanism of activation and cytotoxicity in vitro.
    Jaffar M, Phillips RM, Williams KJ, Mrema I, Cole C, Wind NS, Ward TH, Stratford IJ, Patterson AV.
    Biochem Pharmacol; 2003 Oct 01; 66(7):1199-206. PubMed ID: 14505799
    [Abstract] [Full Text] [Related]

  • 25. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
    Fryatt T, Goroski DT, Nilson ZD, Moody CJ, Beall HD.
    Bioorg Med Chem Lett; 1999 Aug 02; 9(15):2195-8. PubMed ID: 10465544
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1).
    Bian J, Xu L, Deng B, Qian X, Fan J, Yang X, Liu F, Xu X, Guo X, Li X, Sun H, You Q, Zhang X.
    Bioorg Med Chem Lett; 2015 Mar 15; 25(6):1244-8. PubMed ID: 25677663
    [Abstract] [Full Text] [Related]

  • 27. The role of NAD(P)H oxidoreductase (DT-Diaphorase) in the bioactivation of quinone-containing antitumor agents: a review.
    Gutierrez PL.
    Free Radic Biol Med; 2000 Aug 15; 29(3-4):263-75. PubMed ID: 11035255
    [Abstract] [Full Text] [Related]

  • 28. NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones.
    Siegel D, Yan C, Ross D.
    Biochem Pharmacol; 2012 Apr 15; 83(8):1033-40. PubMed ID: 22209713
    [Abstract] [Full Text] [Related]

  • 29. Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
    Newsome JJ, Hassani M, Swann E, Bibby JM, Beall HD, Moody CJ.
    Bioorg Med Chem; 2013 Jun 01; 21(11):2999-3009. PubMed ID: 23635904
    [Abstract] [Full Text] [Related]

  • 30. Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1.
    Hassani M, Cai W, Holley DC, Lineswala JP, Maharjan BR, Ebrahimian GR, Seradj H, Stocksdale MG, Mohammadi F, Marvin CC, Gerdes JM, Beall HD, Behforouz M.
    J Med Chem; 2005 Dec 01; 48(24):7733-49. PubMed ID: 16302813
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
    Han Y, Shen H, Carr BI, Wipf P, Lazo JS, Pan SS.
    J Pharmacol Exp Ther; 2004 Apr 01; 309(1):64-70. PubMed ID: 14718602
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
    Glorieux C, Sandoval JM, Dejeans N, Ameye G, Poirel HA, Verrax J, Calderon PB.
    Life Sci; 2016 Jan 15; 145():57-65. PubMed ID: 26687450
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Kinetics of NAD(P)H:quinone oxidoreductase I (NQO1) inhibition by mitomycin C in vitro and in vivo.
    Gustafson DL, Siegel D, Rastatter JC, Merz AL, Parpal JC, Kepa JK, Ross D, Long ME.
    J Pharmacol Exp Ther; 2003 Jun 15; 305(3):1079-86. PubMed ID: 12649308
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J, Oleschuk CJ, Guziec F, Guziec L, Fiterman DJ, Monterrosa C, Begleiter A.
    Cancer Chemother Pharmacol; 2002 Feb 15; 49(2):101-10. PubMed ID: 11862423
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.